CN113813198A - 一种用于改善面部皱纹与紧致皮肤的营养液及制备方法 - Google Patents
一种用于改善面部皱纹与紧致皮肤的营养液及制备方法 Download PDFInfo
- Publication number
- CN113813198A CN113813198A CN202111123482.6A CN202111123482A CN113813198A CN 113813198 A CN113813198 A CN 113813198A CN 202111123482 A CN202111123482 A CN 202111123482A CN 113813198 A CN113813198 A CN 113813198A
- Authority
- CN
- China
- Prior art keywords
- sodium hyaluronate
- solution
- vitamin
- facial wrinkles
- cross
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000037303 wrinkles Effects 0.000 title claims abstract description 55
- 235000015097 nutrients Nutrition 0.000 title claims abstract description 47
- 230000001815 facial effect Effects 0.000 title claims abstract description 32
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- 239000000243 solution Substances 0.000 claims abstract description 63
- 229920002385 Sodium hyaluronate Polymers 0.000 claims abstract description 50
- 229940010747 sodium hyaluronate Drugs 0.000 claims abstract description 50
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims abstract description 49
- 239000002131 composite material Substances 0.000 claims abstract description 29
- 235000013343 vitamin Nutrition 0.000 claims abstract description 20
- 239000011782 vitamin Substances 0.000 claims abstract description 20
- 229940088594 vitamin Drugs 0.000 claims abstract description 20
- 229930003231 vitamin Natural products 0.000 claims abstract description 20
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 20
- 150000001413 amino acids Chemical class 0.000 claims abstract description 18
- 229920001184 polypeptide Polymers 0.000 claims abstract description 16
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 16
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 16
- 102000008186 Collagen Human genes 0.000 claims abstract description 11
- 108010035532 Collagen Proteins 0.000 claims abstract description 11
- 229920001436 collagen Polymers 0.000 claims abstract description 10
- 238000000034 method Methods 0.000 claims abstract description 7
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 claims abstract 3
- 229960004194 lidocaine Drugs 0.000 claims abstract 3
- 235000001014 amino acid Nutrition 0.000 claims description 17
- 229940024606 amino acid Drugs 0.000 claims description 17
- 239000007864 aqueous solution Substances 0.000 claims description 15
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 12
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims description 8
- 239000004471 Glycine Substances 0.000 claims description 6
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 5
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 5
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 5
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 5
- 229930003471 Vitamin B2 Natural products 0.000 claims description 5
- 235000004279 alanine Nutrition 0.000 claims description 5
- 238000004132 cross linking Methods 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 229960002477 riboflavin Drugs 0.000 claims description 5
- 239000011716 vitamin B2 Substances 0.000 claims description 5
- 235000019164 vitamin B2 Nutrition 0.000 claims description 5
- 108010087806 Carnosine Proteins 0.000 claims description 4
- 108010024636 Glutathione Proteins 0.000 claims description 4
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 claims description 4
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 claims description 4
- 229960003180 glutathione Drugs 0.000 claims description 4
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 2
- 239000004475 Arginine Substances 0.000 claims description 2
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 claims description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 2
- 239000004472 Lysine Substances 0.000 claims description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 2
- 239000004473 Threonine Substances 0.000 claims description 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 2
- 235000003704 aspartic acid Nutrition 0.000 claims description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 2
- 229960003067 cystine Drugs 0.000 claims description 2
- 239000004220 glutamic acid Substances 0.000 claims description 2
- 235000013922 glutamic acid Nutrition 0.000 claims description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 2
- 229960000310 isoleucine Drugs 0.000 claims description 2
- 229930182817 methionine Natural products 0.000 claims description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 2
- 239000004474 valine Substances 0.000 claims description 2
- 235000019156 vitamin B Nutrition 0.000 claims description 2
- 239000011720 vitamin B Substances 0.000 claims description 2
- 235000016709 nutrition Nutrition 0.000 claims 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 2
- 239000007788 liquid Substances 0.000 claims 2
- 210000003491 skin Anatomy 0.000 abstract description 39
- 230000000694 effects Effects 0.000 abstract description 17
- 210000003205 muscle Anatomy 0.000 abstract description 14
- 230000000638 stimulation Effects 0.000 abstract description 10
- 239000000126 substance Substances 0.000 abstract description 9
- 210000004927 skin cell Anatomy 0.000 abstract description 8
- 210000005036 nerve Anatomy 0.000 abstract description 7
- 239000002858 neurotransmitter agent Substances 0.000 abstract description 7
- 230000037394 skin elasticity Effects 0.000 abstract description 7
- 230000001143 conditioned effect Effects 0.000 abstract description 5
- 230000002195 synergetic effect Effects 0.000 abstract description 5
- 230000003111 delayed effect Effects 0.000 abstract description 4
- 239000002504 physiological saline solution Substances 0.000 abstract 1
- 239000000047 product Substances 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 6
- 230000012010 growth Effects 0.000 description 6
- 238000002347 injection Methods 0.000 description 6
- 239000007924 injection Substances 0.000 description 6
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 229920002674 hyaluronan Polymers 0.000 description 5
- 229960003160 hyaluronic acid Drugs 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 230000004071 biological effect Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 108030001720 Bontoxilysin Proteins 0.000 description 3
- 230000003796 beauty Effects 0.000 description 3
- 229940053031 botulinum toxin Drugs 0.000 description 3
- 230000010261 cell growth Effects 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 230000009471 action Effects 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 210000004207 dermis Anatomy 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 230000008921 facial expression Effects 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 231100000956 nontoxicity Toxicity 0.000 description 2
- 239000012466 permeate Substances 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000004904 shortening Methods 0.000 description 2
- 230000037393 skin firmness Effects 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 201000010251 cutis laxa Diseases 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- -1 sodium hyaluronate compound Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
- A61K8/492—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid having condensed rings, e.g. indol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
本发明提供了一种用于改善面部皱纹与紧致皮肤的营养液及制备方法;包括:胶原蛋白1‑0.5份,透明质酸钠复合溶液1‑3份,生理盐水5.5份,利多卡因0.5份;所述透明质酸钠复合溶液包括:交联透明质酸钠6mg/mL,多肽1mg/mL,氨基酸1mg/mL,维生素2μg/mL。本发明还涉及前述用于改善面部皱纹与紧致皮肤的营养液的制备方法。本发明各组分之间还相互协同作用下,形成新的营养物质对皮肤细胞产生营养刺激,使得本发明营养液的修复作用呈现出来,改善真性皱纹,并对各类表情肌进行刺激延缓神经与肌肉之间的神经递质传导,改善表情纹,间接提高皮肤弹性,生成胶原蛋白,综合调理改善面部皱纹。
Description
技术领域
本发明属于护肤品技术领域;尤其涉及一种用于改善面部皱纹与紧致皮肤的营养液及制备方法。
背景技术
随着年龄的增长,人身体的新陈代谢日渐缓慢,而女性30岁以后体内细胞增长速度开始变慢,再生功能减弱,细胞生长无法顺利代谢,有活力的细胞随之减少,面部皮肤上开始出现皱纹,加上面部长期的表情压力,日久便由假性皱纹变成真性皱纹,这是人类生长的自然规律,并非病态。
随着人们社会生活水平的提高,以及对美的向往,祛除皱纹就成了一些人,尤其是女性的渴求。现在普遍采用的祛皱方法有四种:
(1)手术拉皮除皱,即开刀将松驰、多余的面皮切除,这种方法只适用于年龄较大、皮肤已松驰的人;
(2)针剂注射式祛皱,即填充或肉毒素注射,这种方法要在皮下注入异物;
(3)光子嫩肤,通过光的刺激作用,使皮肤细胞再生;
(4)祛皱类的护肤品,涂抹加按摩,这种方法只适用尚未形成真性皱纹的假性皱纹和干纹。
上述方法有的适用人群有局限性,有的有副作用,有的易留痕迹,总之效果不佳,都不理想。
因此如何安全、有效地获得针对皮肤抗皱的有效成分,并应用到化妆品中,是目前亟待解决的问题。
发明内容
本发明的目的是提供了一种用于改善面部皱纹与紧致皮肤的营养液及制备方法。
本发明是通过以下技术方案实现的:
本发明涉及一种用于改善面部皱纹与紧致皮肤的营养液,包括如下重量分数的各组分:
其中,
所述透明质酸钠复合溶液包括以下含量的各组分:
优选地,包括如下重量分数的各组分:
其中,
所述透明质酸钠复合溶液包括以下含量的各组分:
优选地,所述多肽为L-肌肽、谷胱甘肽中的一种或两者的混合。
优选地,所述氨基酸为甘氨酸、亮氨酸、蛋氨酸、酪氨酸、组氨酸、苏氨酸、丙氨酸、异亮氨酸、色氨酸、胱氨酸、赖氨酸、天门冬氨酸、缬氨酸、苯丙氨酸、脯氨酸、丝氨酸、谷氨酸和精氨酸的一种或多种。
优选地,所述氨基酸为甘氨酸、丙氨酸和脯氨酸的一种或多种。
优选地,所述维生素为水溶性维生素。
优选地,所述维生素为B族维生素。
优选地,所述维生素为维生素B2。
优选地,所述述交联透明质酸钠是由非交联透明质酸钠经过化学交联制备而得。
本发明还涉及前述的用于改善面部皱纹与紧致皮肤的营养液的制备方法,包括以下步骤:
步骤1,将透明质酸钠配制成交联透明质酸钠水溶液;
步骤2,将多肽、氨基酸和维生素配制成复合水溶液A;
步骤3,将复合溶液A与交联透明质酸钠水溶液混合,得到交联透明质酸钠复合溶液;
制备过程中各组分用量如下:
皮肤的湿润水平与透明质酸含量密切相关,随着年龄的增长,皮肤中透明质酸含量下降,使皮肤保水功能减弱,产生皱纹。本发明所述的透明质酸钠复合溶液具有较强的黏弹性和润滑性,涂于皮肤表面,可形成一层保湿透气膜,保持皮肤滋润亮泽。更进一步地,本发明所涉及的小分子透明质酸能渗透到真皮层,促进血液微循环,有利于皮肤对营养物质的吸收,起到美容抗皱的保健作用。
本发明所述的多肽为本发明有皱纹的皮肤提高了吸收性,吸收更多的水分及有效成分,为皮肤提供充分的水分及所需的营养成分,其具有高生物活性、易吸收、安全无毒的优势,其美容护肤、抗皱、抗衰老的生理作用与生物效应也被逐渐应用到美容化妆品中。本发明所述的氨基酸用于促进局部细胞生长,加快新细胞的生长,进而缩短修复皱纹的恢复周期。
本发明通过药物配比,所述透明质酸钠复合溶液营养液对皮肤细胞产生营养刺激,增加促进局部细胞生长,改善真性皱纹,并对各类表情肌进行刺激延缓神经与肌肉之间的神经递质传导,改善表情纹,间接提高皮肤弹性,生成胶原蛋白,综合调理改善面部皱纹。
更进一步地,本发明营养液各组分除自身效果以外,各组分之间还相互协同作用下,形成新的营养物质对皮肤细胞产生营养刺激,使得本发明营养液的修复作用呈现出来,改善真性皱纹,并对各类表情肌进行刺激延缓神经与肌肉之间的神经递质传导,改善表情纹,间接提高皮肤弹性,生成胶原蛋白,综合调理改善面部皱纹。
本发明具有以下优点:
(1)本发明与现有的产品相比,现有的肉毒素除皱起效速度快,但是容易引起面部表情僵硬,且药物作用时间长,为3-6个月;且需要长期操作注射使用,并与抗生素类药物会发生毒性增加情况,操作时禁忌要求比较多。而本发明所涉及的营养液产品温和,无副作用,缓慢起效自然;而且本发明所涉及的营养液物质刺激还可以有效地提升皮肤紧致。
(2)本发明原料容易获得,制备方法简单,成本低,无副产品,环保无污染,适应范围广,禁忌点少。
(3)本发明各组分之间还相互协同作用下,形成新的营养物质对皮肤细胞产生营养刺激,使得本发明营养液的修复作用呈现出来,改善真性皱纹,并对各类表情肌进行刺激延缓神经与肌肉之间的神经递质传导,改善表情纹,间接提高皮肤弹性,生成胶原蛋白,综合调理改善面部皱纹。
具体实施方式
下面结合具体实施例对本发明进行详细说明。应当指出的是,以下的实施实例只是对本发明的进一步说明,但本发明的保护范围并不限于以下实施例。
实施例1
本实施例涉及一种用于改善面部皱纹与紧致皮肤的营养液,包括如下重量分数的各组分:
其中,
所述透明质酸钠复合溶液包括以下含量的各组分:
所述多肽为L-肌肽。
所述氨基酸为甘氨酸。
所述维生素为维生素B2。
所述述交联透明质酸钠是由非交联透明质酸钠经过化学交联制备而得。
本实施例还涉及前述的用于改善面部皱纹与紧致皮肤的营养液的制备方法,包括以下步骤:
步骤1,将透明质酸钠配制成交联透明质酸钠水溶液;
步骤2,将多肽、氨基酸和维生素配制成复合水溶液A;
步骤3,将复合溶液A与交联透明质酸钠水溶液混合,得到交联透明质酸钠复合溶液;
制备过程中各组分用量如下:
实施例2
本实施例涉及一种用于改善面部皱纹与紧致皮肤的营养液,包括如下重量分数的各组分:
其中,
所述透明质酸钠复合溶液包括以下含量的各组分:
所述多肽为谷胱甘肽。
所述氨基酸为脯氨酸。
所述维生素为维生素B2。
所述述交联透明质酸钠是由非交联透明质酸钠经过化学交联制备而得。
本实施例还涉及前述的用于改善面部皱纹与紧致皮肤的营养液的制备方法,包括以下步骤:
步骤1,将透明质酸钠配制成交联透明质酸钠水溶液;
步骤2,将多肽、氨基酸和维生素配制成复合水溶液A;
步骤3,将复合溶液A与交联透明质酸钠水溶液混合,得到交联透明质酸钠复合溶液;
制备过程中各组分用量如下:
实施例3
本实施例涉及一种用于改善面部皱纹与紧致皮肤的营养液,包括如下重量分数的各组分:
其中,
所述透明质酸钠复合溶液包括以下含量的各组分:
所述多肽为L-肌肽和谷胱甘肽的混合。
所述氨基酸为甘氨酸、丙氨酸和脯氨酸的的混合。
所述维生素为维生素B2。
所述述交联透明质酸钠是由非交联透明质酸钠经过化学交联制备而得。
本发明还涉及前述的用于改善面部皱纹与紧致皮肤的营养液的制备方法,包括以下步骤:
步骤1,将透明质酸钠配制成交联透明质酸钠水溶液;
步骤2,将多肽、氨基酸和维生素配制成复合水溶液A;
步骤3,将复合溶液A与交联透明质酸钠水溶液混合,得到交联透明质酸钠复合溶液;
制备过程中各组分用量如下:
本发明涉及的上述实施例1-3制备得到的营养液中所涉及的透明质酸钠复合溶液的含量与皮肤的湿润水平密切相关,随着年龄的增长,皮肤中透明质酸含量下降,使皮肤保水功能减弱,产生皱纹。本发明所述的透明质酸钠复合溶液具有较强的黏弹性和润滑性,涂于皮肤表面,可形成一层保湿透气膜,保持皮肤滋润亮泽。更进一步地,本发明所涉及的小分子透明质酸能渗透到真皮层,促进血液微循环,有利于皮肤对营养物质的吸收,起到美容抗皱的保健作用。所述的多肽为本发明有皱纹的皮肤提高了吸收性,吸收更多的水分及有效成分,为皮肤提供充分的水分及所需的营养成分,其具有高生物活性、易吸收、安全无毒的优势,其美容护肤、抗皱、抗衰老的生理作用与生物效应也被逐渐应用到美容化妆品中。所述的氨基酸用于促进局部细胞生长,加快新细胞的生长,进而缩短修复皱纹的恢复周期。
本发明上述实施例1-3涉及的营养液通过药物配比,所述透明质酸钠复合溶液营养液对皮肤细胞产生营养刺激,增加促进局部细胞生长,改善真性皱纹,并对各类表情肌进行刺激延缓神经与肌肉之间的神经递质传导,改善表情纹,间接提高皮肤弹性,生成胶原蛋白,综合调理改善面部皱纹。本发明营养液各组分除自身效果以外,各组分之间还相互协同作用下,形成新的营养物质对皮肤细胞产生营养刺激,使得本发明营养液的修复作用呈现出来,改善真性皱纹,并对各类表情肌进行刺激延缓神经与肌肉之间的神经递质传导,改善表情纹,间接提高皮肤弹性,生成胶原蛋白,综合调理改善面部皱纹。
效果比对
综合上述实施例1-3使用效果与现有产品效果的对比,如表1所示:
表1
本发明与现有的产品相比,现有的肉毒素除皱起效速度快,但是容易引起面部表情僵硬,且药物作用时间长,为3-6个月;且需要长期操作注射使用,并与抗生素类药物会发生毒性增加情况,操作时禁忌要求比较多。而本发明的使用周期为1个月,周期短,见效快,所涉及的营养液产品温和,无副作用,缓慢起效自然;而且本发明所涉及的营养液物质刺激还可以有效地提升皮肤紧致。本发明原料容易获得,制备方法简单,成本低,无副产品,环保无污染,适应范围广,禁忌点少。本发明各组分之间还相互协同作用下,形成新的营养物质对皮肤细胞产生营养刺激,使得本发明营养液的修复作用呈现出来,改善真性皱纹,并对各类表情肌进行刺激延缓神经与肌肉之间的神经递质传导,改善表情纹,间接提高皮肤弹性,生成胶原蛋白,综合调理改善面部皱纹。
以上对本发明的具体实施例进行了描述。需要理解的是,本发明并不局限于上述特定实施方式,本领域技术人员可以在权利要求的范围内做出各种变形或修改,这并不影响本发明的实质。
Claims (10)
1.一种用于改善面部皱纹与紧致皮肤的营养液,其特征在于,包括如下重量分数的各组分:
胶原蛋白1-0.5份,
透明质酸钠复合溶液1-3份,
生理盐水5.5份,
利多卡因0.5份;
其中,
所述透明质酸钠复合溶液包括以下含量的各组分:
交联透明质酸钠6mg/mL,
多肽1mg/mL,
氨基酸1mg/mL,
维生素2μg/mL。
2.如权利要求1所述的用于改善面部皱纹与紧致皮肤的营养液,其特征在于,包括如下重量分数的各组分:
胶原蛋白0.5份,
透明质酸钠复合溶液1份,
生理盐水5.5份,
利多卡因0.5份;
其中,
所述透明质酸钠复合溶液包括以下含量的各组分:
交联透明质酸钠6mg/mL,
多肽1mg/mL,
氨基酸1mg/mL,
维生素2μg/mL。
3.如权利要求1所述的用于改善面部皱纹与紧致皮肤的营养液,其特征在于,所述多肽为L-肌肽、谷胱甘肽中的一种或两者的混合。
4.如权利要求1所述的用于改善面部皱纹与紧致皮肤的营养液,其特征在于,所述氨基酸为甘氨酸、亮氨酸、蛋氨酸、酪氨酸、组氨酸、苏氨酸、丙氨酸、异亮氨酸、色氨酸、胱氨酸、赖氨酸、天门冬氨酸、缬氨酸、苯丙氨酸、脯氨酸、丝氨酸、谷氨酸和精氨酸的一种或多种。
5.如权利要求1所述的用于改善面部皱纹与紧致皮肤的营养液,其特征在于,所述氨基酸为甘氨酸、丙氨酸和脯氨酸的一种或多种。
6.如权利要求1所述的用于改善面部皱纹与紧致皮肤的营养液,其特征在于,所述维生素为水溶性维生素。
7.如权利要求1所述的用于改善面部皱纹与紧致皮肤的营养液,其特征在于,所述维生素为B族维生素。
8.如权利要求1所述的用于改善面部皱纹与紧致皮肤的营养液,其特征在于,所述维生素为维生素B2。
9.如权利要求1所述的用于改善面部皱纹与紧致皮肤的营养液,其特征在于,所述述交联透明质酸钠是由非交联透明质酸钠经过化学交联制备而得。
10.一种如权利要求1所述的用于改善面部皱纹与紧致皮肤的营养液的制备方法,其特征在于,包括以下步骤:
步骤1,将透明质酸钠配制成交联透明质酸钠水溶液;
步骤2,将多肽、氨基酸和维生素配制成复合水溶液A;
步骤3,将复合溶液A与交联透明质酸钠水溶液混合,得到交联透明质酸钠复合溶液;
制备过程中各组分用量如下:
交联透明质酸钠6mg/mL,
多肽1mg/mL,
氨基酸1mg/mL,
维生素2μg/mL。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111123482.6A CN113813198A (zh) | 2021-09-24 | 2021-09-24 | 一种用于改善面部皱纹与紧致皮肤的营养液及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111123482.6A CN113813198A (zh) | 2021-09-24 | 2021-09-24 | 一种用于改善面部皱纹与紧致皮肤的营养液及制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113813198A true CN113813198A (zh) | 2021-12-21 |
Family
ID=78915515
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111123482.6A Pending CN113813198A (zh) | 2021-09-24 | 2021-09-24 | 一种用于改善面部皱纹与紧致皮肤的营养液及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113813198A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115944553A (zh) * | 2022-12-07 | 2023-04-11 | 华熙生物科技股份有限公司 | 寡肽在提高交联透明质酸或其盐稳定性中的应用 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106215244A (zh) * | 2016-08-03 | 2016-12-14 | 爱美客技术发展股份有限公司 | 透明质酸钠的复方溶液及其纠正皮肤皱纹的应用 |
CN109528642A (zh) * | 2018-12-27 | 2019-03-29 | 上海欧邦医疗管理有限公司 | 一种自体修复营养注射液及其应用方法 |
CN111467568A (zh) * | 2019-01-23 | 2020-07-31 | 爱美客技术发展股份有限公司 | 一种交联透明质酸钠复合溶液制剂及其制备方法和应用 |
CN113117144A (zh) * | 2019-12-30 | 2021-07-16 | 上海建华精细生物制品有限公司 | 一种仿生型真皮导入溶液及其应用 |
-
2021
- 2021-09-24 CN CN202111123482.6A patent/CN113813198A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106215244A (zh) * | 2016-08-03 | 2016-12-14 | 爱美客技术发展股份有限公司 | 透明质酸钠的复方溶液及其纠正皮肤皱纹的应用 |
CN109528642A (zh) * | 2018-12-27 | 2019-03-29 | 上海欧邦医疗管理有限公司 | 一种自体修复营养注射液及其应用方法 |
CN111467568A (zh) * | 2019-01-23 | 2020-07-31 | 爱美客技术发展股份有限公司 | 一种交联透明质酸钠复合溶液制剂及其制备方法和应用 |
CN113117144A (zh) * | 2019-12-30 | 2021-07-16 | 上海建华精细生物制品有限公司 | 一种仿生型真皮导入溶液及其应用 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115944553A (zh) * | 2022-12-07 | 2023-04-11 | 华熙生物科技股份有限公司 | 寡肽在提高交联透明质酸或其盐稳定性中的应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105125476B (zh) | 一种抗皱精华液及其制备方法 | |
CN113616566B (zh) | 一种紧致肌肤的护肤精华液及其制备方法 | |
Iorizzo et al. | Biorejuvenation: theory and practice | |
CN103110935B (zh) | 皮肤局部用水解胶原蛋白脂质体及其制备方法 | |
KR101805690B1 (ko) | 화장료 조성물을 포함하는 피부 미용 키트 및 도포방법 | |
KR20120089433A (ko) | 충전제와 섬유아세포 성장 배지를 조합한 주사용 조성물 | |
KR20230107323A (ko) | 효능 촉진 조성물 및 그 용도 | |
CN108261341A (zh) | 双组份用于纠正皮肤皱纹的美白长效水光针剂 | |
CN109350595A (zh) | 一种含有燕窝活性提取液的化妆品及其制备方法和应用 | |
CN111297727A (zh) | 一种美塑治疗组合物及其应用 | |
CN110538093A (zh) | 一种多肽修复液及其制备方法 | |
CN111643389A (zh) | 一种含海洋生物活性肽的抗皱美白修复面膜及其制备方法 | |
CN112043621A (zh) | 一种具有抗衰效果的无防腐多肽组合物 | |
CN104740643A (zh) | 一种稳定的负载生物活性蛋白或多肽的透明质酸溶液 | |
CN107898657A (zh) | 一种含干细胞分泌因子的眼膜 | |
CN113813198A (zh) | 一种用于改善面部皱纹与紧致皮肤的营养液及制备方法 | |
CN113521258A (zh) | 一种改善衰老的组织注射液 | |
CN111961119B (zh) | 多肽在制备促进胶原蛋白分泌的药物或化妆品中的用途 | |
CN109453102A (zh) | 一种多肽面部紧致恢复水 | |
CN113041170A (zh) | 一种涂抹式水光针溶液及其制备方法 | |
CN114146018B (zh) | 保湿抗衰Polypeptides组合物、制备方法及含有其的面霜 | |
CN115957149A (zh) | 水光针精华及其制备方法 | |
KR102113949B1 (ko) | 히알루론산과 글루코오스를 포함하는 피부 재생 및 탄력 개선용 화장료 조성물 | |
CN110227044A (zh) | 一种ha胶原蛋白原液及其制备方法 | |
CN110200826A (zh) | 一种复方植物多肽修护精华液 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20211221 |
|
RJ01 | Rejection of invention patent application after publication |